June 29, 2021 – Center for Diagnostic Imaging (CDI), the nation’s leading subspecialty practice for advanced diagnostic and interventional radiology, announced its rebranding as Rayus Radiology, a major milestone in the company’s 40

June 29, 2021 —  UPMC Hillman Cancer Center will be the first cancer center in the eastern United States, and one of just a handful in the country, to offer the most advanced radiotherapy system for treating patients.

June 29, 2021 — Lung cancer remains the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for 80-85 percent cases of lung cancer and when diagnosed early, has a five-year survival rate of 50-80 percent. Black patients have lower overall incidence of NSCLC than white patients, but are more likely to be diagnosed at later stages.

June 28, 2021 — The U.S. Food and Drug Administration (FDA) approved a new imaging agent for detection of prostate cancer, providing a more effective imaging approach to detect the spread of cancer to other parts of the body.

June 28, 2021 — Siemens Healthineers and Prisma Health announced today a 10-year strategic relationship to help create a better state of health for South Carolina. This Value Partnership is focused on healthcare innovation, workforce development, and improving health care for patients and communities served by Prisma Health.

June 28, 2021 — RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier universitaire vaudois (CHUV) in Lausanne, Switzerland, which will include orders for RayStation RayCare and RayIntelligence. 

June 25, 2021 — Breast cancer recently 

June 25, 2021 — Alliance HealthCare Services, Inc., a leading national provider of radiology and oncology solutions to hospitals, health systems and physician groups, announced today that it has entered into an agreement to be acquired for $820 million by Akumin Inc., a premier provider of freestanding outpatient radiology services in the U.S.

June 25, 2021 — Patients with primary lung cancer detected using low-dose computed tomography screening are at reduced risk of developing brain metastases after diagnosis, according to a study published in the Journal of Thoracic Oncology.

Subscribe Now